Psf3 is a prognostic biomarker in lung adenocarcinoma: a larger trial using tissue microarrays of 864 consecutive resections [THORACIC]

CONCLUSIONS
The present findings strengthened our previous data demonstrating that high Psf3 expression in primary lung adenocarcinoma plays an important role in disease progression and is a prognostic indicator, particularly in early-stage adenocarcinoma.

Source: European Journal of Cardio-Thoracic Surgery - October 4, 2016 Category: Cardiovascular & Thoracic Surgery Authors: Tauchi, S., Sakai, Y., Fujimoto, S., Ogawa, H., Tane, S., Hokka, D., Tanaka, Y., Nishio, W., Yoshimura, M., Yanagita, E., Itoh, T., Hayashi, Y., Maniwa, Y. Tags: Lung - other, Lung - basic science THORACIC Source Type: research